PRESS RELEASE published on 02/29/2024 at 20:40, 2 years 8 months ago BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for financing of growth initiatives. The bonds have an interest rate of 6.52% p.a. and a maturity date of 5 September 2026 Financing Convertible Bond BRAIN Biotech AG Growth Initiatives EUR 5.0 Million
BRIEF published on 02/29/2024 at 20:11, 2 years 8 months ago BRAIN Biotech AG Announces Issuance of EUR 5 Million Convertible Bond Convertible Bonds Shareholder Rights Financial Strategy BRAIN Biotech AG Corporate Financing
BRIEF published on 02/29/2024 at 20:11, 2 years 8 months ago BRAIN Biotech AG annonce l'émission d'une obligation convertible de 5 millions d'euros Stratégie Financière BRAIN Biotech SA Liens Convertibles Financement D'entreprise Droits Des Actionnaires
PRESS RELEASE published on 02/29/2024 at 20:06, 2 years 8 months ago EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights BRAIN Biotech AG issues EUR 5 million convertible bond without subscription rights, to be issued on 5 March 2024. Bonds have 6.52% interest rate and due for repayment in 2026 Convertible Bond BRAIN Biotech AG Subscription Rights Interest Rate Repayment
BRIEF published on 02/28/2024 at 07:30, 2 years 8 months ago BRAIN Biotech AG : Bilan du premier trimestre de l'exercice 2023/24 Croissance Organique Rapport Financier BRAIN Biotech AG BioScience BioProduits
BRIEF published on 02/28/2024 at 07:30, 2 years 8 months ago BRAIN Biotech AG: Review of the first quarter of the 2023/24 financial year Financial Report Organic Growth BRAIN Biotech AG BioScience BioProducts
PRESS RELEASE published on 02/28/2024 at 07:30, 2 years 8 months ago 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 BRAIN Biotech AG reports optimistic outlook for fiscal year 2023/24 with strong start in BioScience business. Quarterly report includes details on revenue and segment performance Revenue Growth Financial Performance BRAIN Biotech AG Fiscal Year 2023/24 BioScience Business
PRESS RELEASE published on 09/28/2023 at 10:30, 3 years 1 month ago BRAIN Biotech AG: BRAIN Biotech AG´s Akribion Genomics team wins first prize at the “BioRiver Boost!” startup competition
PRESS RELEASE published on 09/14/2023 at 10:30, 3 years 2 months ago BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E®
PRESS RELEASE published on 09/12/2023 at 15:45, 3 years 2 months ago BRAIN Biotech AG: Scientist from BRAIN Biotech AG receives VAAM Innovation Award for the discovery of a novel CRISPR nuclease family
Published on 11/20/2026 at 15:00, 19 hours 42 minutes ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 19 hours 52 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 20 hours 42 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 21 hours 12 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 21 hours 12 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 23:45, 10 hours 57 minutes ago APEC CEO Summit 2026 Concludes Successfully in Shenzhen
Published on 11/20/2026 at 22:39, 12 hours 3 minutes ago ABIVAX: Abivax publie une déclaration concernant le rapport d'un vendeur à découvert
Published on 11/20/2026 at 21:36, 13 hours 6 minutes ago EQS-Adhoc: Global Health Care AG: Board of Directors proposes sale of milon stake based on an equity value of EUR 23.3 million – subscription right for all shareholders
Published on 11/20/2026 at 20:49, 13 hours 53 minutes ago E-PANGO: Jugement du Tribunal Judiciaire de Paris relatif au contentieux avec le groupement RIVP-HENEO-HSF
Published on 11/20/2026 at 18:34, 16 hours 8 minutes ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 16 hours 8 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 17 hours 7 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 17 hours 7 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026
Published on 11/19/2026 at 19:00, 1 day 15 hours ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR